Kidney Disease, Chronic Clinical Trial
Official title:
Effect of JATENZO® Therapy on Testosterone and Hemoglobin Concentrations in Hypogonadal Men With Chronic Kidney Disease
This study in being conducted in men who have low testosterone and chronic kidney disease. The investigators will evaluate the effects of an oral testosterone preparation, JATENZO, on testosterone levels and hemoglobin (red blood cells).
- Purpose. The purpose of this research is to find out if JATENZO will help increase testosterone levels in men with hypogonadism and chronic kidney disease, determine if there is any improvement in testosterone levels, hemoglobin (red blood cells), muscle strength, lean mass and sexual function. - The dug will be daily for 6 months. Study Procedures. Every 2-4 weeks, the study participant will come in person for a research visit. Investigators will collect a blood sample at certain visits, do a brief physical exam, and obtain vital signs such as height, weight, blood pressure. The study also involves completing questionnaires, measuring body composition by a scan and testing muscle strength. The dose of JATENZO may be adjusted based on the testosterone levels. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03907657 -
Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau
|
Phase 2 | |
| Not yet recruiting |
NCT06223750 -
Virtual Kidney Check and Follow-up
|
N/A | |
| Completed |
NCT02468401 -
Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions
|
N/A | |
| Completed |
NCT02238067 -
Survey on Anemia Therapy in Patients With Chronic Kidney Disease Not on Dialysis
|
N/A | |
| Completed |
NCT01194154 -
A Study of Methoxy Polyethylene Glycol-epoetin Beta (Mircera) in Participants With Chronic Kidney Disease (PRIMAVERA)
|
Phase 2 | |
| Completed |
NCT02263833 -
An Observational, Prospective, Safety Study of Mircera (Monopegylated Epoetin Beta) in Clinical Practice
|
N/A | |
| Active, not recruiting |
NCT04078750 -
PLATO - Medication Adherence in Transplant Recipients
|
N/A | |
| Recruiting |
NCT05490511 -
Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus
|
Phase 1 | |
| Terminated |
NCT05747053 -
Personalization of Immunosuppressive Treatment for Organ Transplant Recipients
|
||
| Completed |
NCT03189212 -
Feasibility Study of Telemedicine for Dialysis Patients Awaiting Transplantation
|
N/A | |
| Enrolling by invitation |
NCT05374291 -
The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD
|
Phase 3 | |
| Recruiting |
NCT05033054 -
Effect of SGLT2i on Cardiovascular Biomarkers in Patients With Type 2 Diabetes and CKD Stage 3b-4
|
||
| Completed |
NCT05064267 -
Hemostatic Profiles in Pediatric CKD
|
||
| Not yet recruiting |
NCT06069518 -
Continuous Glucose Monitoring in Patients With Diabetes on Peritoneal Dialysis
|
||
| Not yet recruiting |
NCT03590067 -
Oral Findings in a Group of Egyptian Pediatric Patients at Endstage Renal Disease
|
||
| Recruiting |
NCT04014127 -
Coronary Microvascular Dysfunction in Chronic Kidney Disease
|
||
| Recruiting |
NCT04626323 -
Randomized Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney Disease
|
Phase 2 | |
| Not yet recruiting |
NCT05774392 -
An Observational Study of Patients With Chronic Kidney Disease
|
||
| Not yet recruiting |
NCT06343727 -
A High Protein Egg White Pudding for People With Kidney Failure (HiPE KF)
|
N/A | |
| Completed |
NCT04515797 -
QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/Pibrentasvir
|
Phase 4 |